IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q1 2019 Holdings

Filed 2019-05-07 | 4 holdings | $13.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc(ADMA)COM000899104$13.7M3,608,17199.6%
Aimmune Therapeutics Inc.(AIMT)COM00900T107$44.5K1,990,0000.3%
Transenterix Inc.COM NEW89366M201$5.7K2,389,3520.0%
Cidara Therapeutics Inc.COM171757107$2.7K1,021,1480.0%